Because high-risk MM is generally associated with drug resistance, we measured CHEK1 expression in two pairs of drug-susceptible and -resistant cell lines, the MM1.S and MM1.R lines, which are susceptible and resistant to dexamethasone, respectively, and ANBL6 WT and BTZ-resistant cells. The gene discussed is CHEK1; the disease is Miyoshi myopathy.